
Retatrutide Mega Bundle
The Retatrutide Mega Bundle is packed in Australia by Australian Research Peptides, for laboratories and researchers, around three 10 mg vials of a 39-amino-acid peptide reported to bind the GIP, GLP-1 and glucagon receptors, studied in metabolic research. Sixty insulin syringes and two 3 mL vials of bacteriostatic water complete the kit, which ships to all states and territories. Nothing is decanted or repackaged. HPLC-tested batches, for in vitro research purposes only.
Includes 3 × Retatrutide 10 mg + 2 × BAC Water 3 mL + 3 × Insulin Syringes 20 Pack
Free Standard tracked post — this bundle clears the $199 threshold on its own, with nothing added.
Frequently Bought Together
About Retatrutide Mega Bundle
The Retatrutide Mega Bundle is an eight-item kit: three 10 mg Retatrutide vials, two 3 mL vials of bacteriostatic water and three packs of twenty insulin syringes. Nothing is decanted, repackaged or mixed together. Each item arrives sealed in the same container it would have arrived in on its own, so the bundle is a way of buying three listings at once rather than a ninth product.
They ship together because a freeze-dried peptide is not usable on the day it lands. Retatrutide is supplied as a dry solid, so a diluent and something graduated to measure with are both needed before any benchwork begins, and forgetting one of them is the commonest gap on a first order.
Each component keeps its own listing. Bacteriostatic water is sterile water containing 0.9% benzyl alcohol as a preservative, and the insulin syringes are ordinary graduated 1 mL units. Every peptide batch is HPLC-tested and mass-spectrometry confirmed before release. The compound itself is described below.
Retatrutide is studied in metabolic research. Eli Lilly developed the molecule and has carried it from early work through large late-stage studies. In laboratory receptor assays it binds the GIP, GLP-1 and glucagon receptors. That triple target separates it from semaglutide, which acts at GLP-1 alone, and from tirzepatide, which acts at two.
The molecule is one continuous chain of 39 amino acids, engineered from a GIP peptide backbone. The chain carries a C20 fatty di-acid, meaning a twenty-carbon fatty group bonded onto it. That group is described as binding albumin in blood, which is the design feature reported to make the molecule long-acting.
Australian Research Peptides supplies retatrutide as a freeze-dried solid, white to off-white, sealed in a tamper-evident glass vial. It is also written and searched as reta or retat. The material is a laboratory reference compound, characterised for benchwork in glassware and cell culture rather than for any use in a living subject.
Content reviewed
Further reading: Retatrutide Price in Australia
Retatrutide Mega Bundle specifications, storage and shipping
- Compound: Retatrutide Mega Bundle
- Appearance: Three vials of lyophilised powder, two vials of clear colourless solution, sixty capped syringes
- Sizes & SKUs: 3 vials + 2 water + 60 syringes (ARP-RTRT8)
- Presentation: sealed glass vial
- Form: Lyophilised Powder
- Grade: High-purity research grade
- Purity verification: HPLC-assayed on every batch to a minimum of 99% purity — the measured result for your batch is stated on its Certificate of Analysis
- Identity confirmation: Mass spectrometry
- Classification: In vitro research purposes only — laboratory reference material
- Lyophilised — long term
- −20 °C to −80 °C — long-term storage
- Lyophilised — short term
- 2–8 °C — refrigerated, for a few months
- Reconstituted
- 2–8 °C — use within 8–12 weeks




